Zhang Dongzhi
Président chez JIALIJIA GROUP CORPORATION LIMITED
Fortune : 200 $ au 31/03/2017
Profil
Zhang Dongzhi is currently the Chairman, President & Chief Executive Officer at China Tongzilian Group Share Ltd., Inc. and the Chairman at JiaLiJia Group Corp.
Ltd.
Previously, Mr. Dongzhi was the Chairman, President & Chief Executive Officer at ZhongTai Biotechnology Pharmaceutical Group Co., Ltd.
Mr. Dongzhi holds an MBA from Yangtze University and an undergraduate degree from Central Police University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
China Tongzilian Group Share Ltd., Inc.
100,00% | 31/12/2016 | 20 000 000 ( 100,00% ) | 200 $ | 31/03/2017 |
Postes actifs de Zhang Dongzhi
| Sociétés | Poste | Début |
|---|---|---|
| JIALIJIA GROUP CORPORATION LIMITED | Président | 15/12/2018 |
| China Tongzilian Group Share Ltd., Inc. | Directeur Général | 12/09/2016 |
Anciens postes connus de Zhang Dongzhi
| Sociétés | Poste | Fin |
|---|---|---|
ZhongTai Biotechnology Pharmaceutical Group Co., Ltd.
 ZhongTai Biotechnology Pharmaceutical Group Co., Ltd. Financial ConglomeratesFinance Zhongtai Biotechnology Pharmaceutical Group Co., Ltd. operates as a development stage company. Its business purpose is to seek the acquisition of or merger with, an existing company. The company was founded on July 27, 2015 and is headquartered in Changzhou, China. | Directeur Général | - |
Formation de Zhang Dongzhi
| Yangtze University | Masters Business Admin |
| Central Police University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JIALIJIA GROUP CORPORATION LIMITED | Finance |
| Entreprise privées | 2 |
|---|---|
ZhongTai Biotechnology Pharmaceutical Group Co., Ltd.
ZhongTai Biotechnology Pharmaceutical Group Co., Ltd. Financial ConglomeratesFinance Zhongtai Biotechnology Pharmaceutical Group Co., Ltd. operates as a development stage company. Its business purpose is to seek the acquisition of or merger with, an existing company. The company was founded on July 27, 2015 and is headquartered in Changzhou, China. | Finance |
| China Tongzilian Group Share Ltd., Inc. |
